Clinical examination is the basis of a good assessment of a patient with Graves' orbitopathy. This study gives recommendations of the European orbitopathy group related to the activity and severity of the disease. The activity of the disease is estimated on the basis of infl ammation of the soft tissues and the sum of clinical activity is used here. Severity of the disease is estimated by measuring exophthalmos, palpebral aperture, infection of soft tissues, extraocular muscles, corneal infection and optical nerve.
some of them do not have dyplopiae due to the symmetrical effects on both orbits, amblyopia or the fact that restriction happens in extreme situations which are not so important for everyday activities. Optical neuropathy appears rarely and may be observed in unclear eyesight which cannot improve even with one eye closed, reduced recognition of colours and problems in the visual fi eld (4) . GO has its natural course which is very often changeable; eye symptoms may become worse, stay unchanged for a long period of time or spontaneously improve. Generally speaking, there is an infl ammatory phase of the progressive course of the disease (active phase), after which there is a period without important changes (stable plateau phase) and fi nally the improvement phase (inactive phase) (5, 6, 7) .
It is very important to separate the activity from the severity of the disease. Activity refers to the degre of infl ammation of soft tissues, and severity determines the degree of functional and cosmetic changes. The fastest way to determine activity is a clinical examination using a clinical overview with the help of the score of clinical activity (Clinical activity score, CAS) (8), although some other visual and laboratory parameters are also considered to be indicators of the disease, e.g. TSH receptor At, reduced eye muscle refl ectivity on A-mode ultrasonography, prolonged T2 relaxation time during magnetic resonance examination, positive octreoscan and increased values of GAG in urine.
European group for orbitopathies (EUGOGO) was founded in 1999 by nine European thyroid-ophthalmology centres. It expanded over the time and in 2011, Serbia also became a member of this association. It is an association of endocrinologists, ophtalmologists, epidemiologists and radiologists founded with the aim to improve the treatment of patients with Graves' orbitopathy. In order to do this, it is necessary to understand the disease (patophysilogical process, natural clinical course of the disease) as well as to do a detailed examination of the patient. Clinical examination is extremely important since the treatment depends on the activity degree and severity of the disease. E.g. medium and severe orbitopathy are treated with corticosteroids in case the disease is active, and if it is inactive it is treated by surgery (9, 10, 11) . In order to standardise the examination of GO subjective components ( infl ammation of soft tissues), a specifi c methodology was suggested which related to the use of the ophthalmology atlas with colour photographs which would ensure precise defi nition of the eye symptoms and give examples for the assessment of severity of the disease (12, 13) . Diplopiae -subjective score ( 0=absent; 1= intermittent; 2=inconstant, e.g. in the extreme position; 3= constant, present in the primary position)
Infection of eye muscles ( duction in degrees) (14) Corneal infection ( absent/punctiform keratopathy/ulcerations) Infection of the optical nerve ( visus corrected as much as possible, optical discus, colour eyesight, afferent pupillary defect (absent/present) with an examination of the visual fi eld if the compression of the optical nerve is suspected).
Upon clinical examination, it is suggested to do the classifi cation in the following way:
EUGOGO recommendations for the classifi cation of GO severity (11):
1. GO endangering the eyesight: patients with dysthyroid optic neuropathy and/ or damaged cornea. This demands urgent treatment. 2. medium to severe GO: Patients have one or more of the following symptoms: eyelid retraction ≥2mm, medium to severe infection of soft tissues, exophthalmos ≥3mm, constant or inconstant diplopiae. Treatment is done by immunosuppresives or surgical decompression. 3. mild GO: Patients have one or more of the following symptoms: eyelid retraction <2mm, mild infection of soft tissues, exophthalmos <3mm, intermittent or no diplopiae and corneal irritation (sensitive to lubricants). Changes in the eyes have very little effect on daily activites so that immuno suppressives and surgical treatment are not justifi ed.
EUGOGO recommends that doctors in primary health protection, general practitioners, specialists of internal medicine and inexperienced endocrinologists, when treating patients with Graves' orbitopathy, should send all of them except those with mild forms of the disease to tertiary institutions where teams of endocrinologists and ophthalmologists will do examinations in the above-mentioned way and thus make a decision on the type of treatment (9, 11) .
